EBIT: Income before interest and taxes.
Dogwood Therapeutics, Inc (DWTX) had EBIT of $-3.92M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.81M |
|
-- |
|
-- |
|
$3.92M |
|
$-3.92M |
|
$0.12M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
|
EBIT |
$-3.92M |
$-3.91M |
|
1.91M |
|
1.91M |
|
$-1.99 |
|
$-1.99 |
|
| Balance Sheet Financials | |
$14.70M |
|
$0.02M |
|
$81.99M |
|
$96.69M |
|
$1.89M |
|
-- |
|
$12.27M |
|
$14.15M |
|
$-18.12M |
|
$0.78M |
|
$82.54M |
|
1.34M |
|
| Cash Flow Statement Financials | |
$-8.71M |
|
-- |
|
$7.25M |
|
$14.85M |
|
$13.40M |
|
$-1.45M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.02% |
|
-488.92% |
|
-3.94% |
|
-4.61% |
|
$61.60 |
|
$-4.56 |
|
$-4.56 |
|